Business Description
GlycoMimetics Inc
NAICS : 325412
SIC : 2834
ISIN : US38000Q1022
Description
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 51.66 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -5.53 | |||||
| Beneish M-Score | 3.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 18 | |||||
| 3-Year EPS without NRI Growth Rate | 19.7 | |||||
| 3-Year FCF Growth Rate | 13.8 | |||||
| 3-Year Book Growth Rate | -38.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.3 | |||||
| 9-Day RSI | 24.75 | |||||
| 14-Day RSI | 29.46 | |||||
| 6-1 Month Momentum % | 154.78 | |||||
| 12-1 Month Momentum % | 109.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.41 | |||||
| Quick Ratio | 6.41 | |||||
| Cash Ratio | 6.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.5 | |||||
| Shareholder Yield % | -23.96 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -392750 | |||||
| Net Margin % | -369000 | |||||
| FCF Margin % | -349020 | |||||
| ROE % | -75.34 | |||||
| ROA % | -65.64 | |||||
| ROIC % | -858.39 | |||||
| ROC (Joel Greenblatt) % | -4187.1 | |||||
| ROCE % | -79.94 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.09 | |||||
| Price-to-Tangible-Book | 3.09 | |||||
| EV-to-EBIT | -1.97 | |||||
| EV-to-EBITDA | -1.98 | |||||
| EV-to-Revenue | 7728.2 | |||||
| EV-to-FCF | -2.21 | |||||
| Price-to-Net-Current-Asset-Value | 3.25 | |||||
| Price-to-Net-Cash | 3.44 | |||||
| Earnings Yield (Greenblatt) % | -50.76 | |||||
| FCF Yield % | -29.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GLYC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlycoMimetics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.01 | ||
| EPS (TTM) ($) | -0.58 | ||
| Beta | 2.26 | ||
| Volatility % | 68.32 | ||
| 14-Day RSI | 29.46 | ||
| 14-Day ATR ($) | 0.218965 | ||
| 20-Day SMA ($) | 2.51425 | ||
| 12-1 Month Momentum % | 109.29 | ||
| 52-Week Range ($) | 1.11 - 3.5299 | ||
| Shares Outstanding (Mil) | 64.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GlycoMimetics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlycoMimetics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
GlycoMimetics Inc Frequently Asked Questions
What is GlycoMimetics Inc(GLYC)'s stock price today?
The current price of GLYC is $1.86. The 52 week high of GLYC is $3.53 and 52 week low is $1.11.
When is next earnings date of GlycoMimetics Inc(GLYC)?
The next earnings date of GlycoMimetics Inc(GLYC) is 2024-05-03 Est..
Does GlycoMimetics Inc(GLYC) pay dividends? If so, how much?
GlycoMimetics Inc(GLYC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers